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IMPACT OF THE COVID-19 PANDEMIC IN A
SPECIALIZED TUBERCULOSIS UNIT
IMPACTO DE LA PANDEMIA COVID-19 EN UNA UNIDAD ESPECIALIZADA DE TUBERCULOSIS
Xiomara Bernal-Duran1,a , Ángel Cubas-Alcántara1,a , Karina Narváez-Hidalgo 1,a , María Navarro-Castro 1,a
, Renzo Villanueva-Villegas 1,2,3,b , Félix Llanos-Tejada 1,2,3,b

Mr. Editor
The COVID-19 pandemic has negatively aﬀected other disease prevention and control programs that could
cause more deaths than the coronavirus itself (1), and also having substantial consequences for other
domains, such as social impact: slowing economic growth and increasing rates of unemployment, poverty,
and food insecurity.
The pandemic context generated a particular concern for the regular provision of health services since
human and infrastructure resources for medical care were transferred to services related to COVID-19, for this
reason, patients with health problems health not related to COVID-19 were abandoned by not having access
to health care services(2). Consequently, control measures and epidemiological surveillance of tuberculosis
(TB) were aﬀected, which would produce an increase in the number of cases (3).
Peru is one of the countries with the highest incidence of tuberculosis, both sensitive and resistant, in the
world. Although the public health measures adopted in the country have improved the care, diagnosis and
management of People Aﬀected by TB (PAT), there are still limitations in the control of the disease, especially
in multidrug-resistant TB (MDR), People Deprived of Freedom (PDF) and People Living with HIV (PLWHIV), as
referred to by Guin et al.(4)
According to data from the World Bank, between 40 and 60 million people will have fallen into extreme
poverty in 2020 as a result of COVID-19, knowing the close relationship between poverty and TB, an increase
in prevalence and incidence is expected to medium and long term (1).
Both COVID-19 and TB aﬀect the respiratory system, primarily the lungs, and have similar symptoms such as
cough, fever, and shortness of breath, although the severity and duration of symptoms vary (1). But, COVID-19
has overtaken TB as the infectious disease with the highest death rate per day (5). Comorbidities such as
chronic kidney disease, diabetes, lung cancer, and chronic obstructive pulmonary disease (COPD), especially
secondary to smoking, have a higher risk of hospitalization and death when related to COVID-19 and/or TB (6).
A preventive measure to prevent the spread of SARS-CoV-2 was mandatory social isolation at home, however,
this measure could facilitate the transmission of TB, due to prolonged contact at home (7).
During the COVID-19 pandemic (2020-2021), in the Specialized Tuberculosis Unit of the Pulmonology
Service at Hospital Nacional Dos de Mayo, a more than double increase in the prevalence of hospitalized
patients with Type 2 Diabetes Mellitus (DM2) and TB (Figure 1) compared to the periods prior to the pandemic
(2015-2019); which could be explained as a secondary eﬀect of poor control of the disease, late diagnosis and
inadequate follow-up of chronic diseases, due to the insuﬃcient functioning of the rst level of care (8).
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Figure 1. . Annual frequency of cases hospitalized for tuberculosis and type 2 diabetes mellitus (green line),
tuberculosis and HIV (blue line), and deaths from tuberculosis (red line).
The average uptake of respiratory symptoms
decreased by 46.8% during the pandemic period,
compared to the pre-pandemic period (Figure 2);
however, no change was found in the percentage of
positive smear microscopy when we compared

the period prior to the pandemic (3.7%) with the period
of the pandemic (3.8%). In addition, we evidenced that
there was no change in the average number of
hospitalizations of patients with MDR-TB (9).

SINTOMÁTICOS RESPIRATORIOS CON TBC BK+

Figure 2. Annual frequency of detection of respiratory symptoms (blue line) and
annual frequency of positive smears for M. tuberculosis (orange line)

Finally, the average number of deaths hospitalized for
tuberculosis increased by 60% during the pandemic
(Figure 1), compared to the previous period; this would
be due to the late diagnosis of the disease and
hospitalization due to severe complications, such as
meningoencephalitis (MEC), TB and TB with respiratory
failure (10).
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Today, two years after the pandemic began in Peru, the
ambitious challenge is to mitigate its eﬀects, without
neglec ting pre - existing diseases, especially
remembering that both infections share social
determinants of health, related to poverty, which today
would have increased after con nement throughout
Peru.

Pág. 651

2

Bernal-Duran et al.: Impact of the Covid-19 pandemic in a specialized Tuberculosis uni

In addition, any investment made in the management
of the coronavirus should be used for the care of TB
patients; citing as examples eﬀective social isolation,
hand washing, and mandatory use of a mask in closed
public places. Similarly, the implementation of new
molecular laboratories to optimize and speed

up the diagnosis of TB in the future. The current
situation is radically changing the way we manage TB
for the foreseeable future and unmasking
vulnerabilities; it is necessary to get back on track, in
order to avoid an unprecedented health crisis (11).
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